Sheehan D V
Psychiatr Clin North Am. 1985 Mar;8(1):49-62.
This article reviews the evidence on the efficacy of monoamine oxidase inhibitors (MAOIs) and of alprazolam in the treatment of panic disorder and agoraphobia. It also presents guidelines to the clinician on how to implement these treatments in practice.
本文综述了单胺氧化酶抑制剂(MAOIs)和阿普唑仑治疗惊恐障碍及广场恐惧症疗效的相关证据。同时,也为临床医生提供了在实际中如何实施这些治疗的指导原则。